Granisetron is equivalent to ondansetron for prophylaxis of chemotherapy-induced nausea and vomiting
- 1 December 2000
- Vol. 89 (11) , 2301-2308
- https://doi.org/10.1002/1097-0142(20001201)89:11<2301::aid-cncr19>3.0.co;2-6
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Recommendations for the Use of Antiemetics: Evidence-Based, Clinical Practice GuidelinesJournal of Clinical Oncology, 1999
- Serotonin Receptor Antagonists in Prophylaxis of Acute and Delayed Emesis Induced by Moderately Emetogenic, Single-Day ChemotherapyAmerican Journal of Clinical Oncology, 1999
- Efficacy of 5-HT3 receptor antagonists in radiotherapy-induced nausea and vomiting: A quantitative systematic reviewEuropean Journal Of Cancer, 1998
- Consensus proposal for 5HT 3 antagonists in the prevention of acute emesis related to highly emetogenic chemotherapySupportive Care in Cancer, 1998
- Comparison of single-dose oral granisetron versus intravenous ondansetron in the prevention of nausea and vomiting induced by moderately emetogenic chemotherapy: a multicenter, double-blind, randomized parallel study.Journal of Clinical Oncology, 1998
- An overview of randomised studies comparing 5-HT3 receptor antagonists to conventional anti-emetics in the prophylaxis of acute chemotherapy-induced vomitingEuropean Journal Of Cancer, 1997
- Comparison of granisetron, ondansetron, and tropisetron in the prophylaxis of acute nausea and vomiting induced by cisplatin for the treatment of head and neck cancer: a randomized controlled trialCancer, 1996
- Prevention of Delayed Emesis by a Single Intravenous Bolus Dose of 5-HT3-Receptor- Antagonist in Moderately Emetogenic ChemotherapyJournal of Chemotherapy, 1996
- Is Navoban® (tropisetron) as effective as Zofran® (ondansetron) in cisplatin-induced emesis?Anti-Cancer Drugs, 1995
- 5-HT3 receptor antagonists in the prophylaxis of acute vomiting induced by moderately emetogenic chemotherapy—A randomised studyEuropean Journal Of Cancer, 1993